A Comparison of Patient and Physician-Rated New York Heart Association Class in a Community-Based Heart Failure Clinic

Journal of Cardiac Failure

Volumn 14, Issue 5, 2008, Pages 379-387

  Goode, Kevin M ^a   Nabb, Samantha ^a   Cleland, John G F ^a   Clark, Andrew L ^a  

^a CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

Heart failure; Prognosis; Symptom score

Indexed keywords

ADULT; AGED; ARTICLE; COMMUNITY CARE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASSIFICATION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SYMPTOM;

AGED; AMBULATORY CARE FACILITIES; COMMUNITY HEALTH SERVICES; EXERCISE TEST; FEMALE; GREAT BRITAIN; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; WALKING;

EID: 44349153109     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2008.01.014     Document Type: Article

References (45)

1. Petrie M.C., Berry C., Stewart S., and McMurray J.J. Failing ageing hearts. Eur Heart J 22 (2001) 1978-1990
2. Hobbs F.D.R., Kenkre J.E., Roalfe A.K., et al. Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J 23 (2002) 1867-1876
3. Heo S., Moser D.K., Lennie T.A., Zambroski C.H., and Chung M.L. A comparison of health-related quality of life between older adults with heart failure and healthy older adults. Heart Lung 36 (2007) 16-24
4. Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
5. Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail 12 (2006) 10-38
6. The criteria committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th Edition (1994), Little, Brown & Co, Boston, Mass:
7. Bohm M., Maack C., Wehrlen-Grandjean M., and Erdmann E. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)). Z Kardiol 92 (2003) 668-676
8. Kjekshus J., Dunselman P., Blideskog M., et al. A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics. Eur J Heart Fail 7 (2005) 1059-1069
9. Poole-Wilson P.A., Swedberg K., Cleland J.G., et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 362 (2003) 7-13
10. Brunner-La Rocca H.P., Buser P.T., Schindler R., et al. Management of elderly patients with congestive heart failure-design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF). Am Heart J 151 (2006) 949-955
11. Muller K., Gamba G., Jaquet F., and Hess B. Torsemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV-efficacy and quality of life. Eur J Heart Fail 5 (2003) 793-801
12. Abdulla J., Burchardt H., Abildstrom Z., Kober L., and Torp-Pedersen C. The angiotensin converting enzyme inhibitor trandolapril has neutral effect on exercise tolerance or functional class in patients with myocardial infarction and reduced left ventricular systolic function. Eur Heart J 24 (2003) 2116-2122
13. Goldman L., Hashimoto B., Cook E.F., and Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation 64 (1981) 1227-1234
14. Raphael C., Briscoe C., Davies J., et al. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 93 (2007) 476-482
15. Ekman I., Cleland J.G., Andersson B., and Swedberg K. Exploring symptoms in chronic heart failure. Eur J Heart Fail 7 (2005) 699-703
16. Bart B.A., Shaw L.K., McCants Jr. C.B., et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 30 (1997) 1002-1008
17. van den Broek S.A., van Veldhuisen D.J., de Graeff P.A., et al. Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 70 (1992) 359-363
18. Stelken A.M., Younis L.T., Jennison S.H., et al. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol 27 (1996) 345-352
19. Bettencourt P., Ferreira A., Dias P., et al. Predictors of prognosis in patients with stable mild to moderate heart failure. J Card Fail 6 (2000) 306-313
20. Yeo K.T., Wu A.H., Apple F.S., et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta 338 (2003) 107-115
21. How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure. Eur Heart J 19 (1998) 990-1003
22. Lubien E., DeMaria A., Krishnaswamy P., et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 105 (2002) 595-601
23. Pritchett A.M., Jacobsen S.J., Mahoney D.W., et al. Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol 41 (2003) 1036-1043
24. Otto C.M. Textbook of Clinical Echocardiography. (3rd Edition) (2004), Elsevier Saunders
25. Maron B.J., McKenna W.J., Danielson G.K., et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42 (2003) 1687-1713
26. Zoghbi W.A., Enriquez-Sarano M., Foster E., et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16 (2003) 777-802
27. Cleland J.G.F., Tendera M., Adamus J., et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 27 (2006) 2338-2345
28. Cleland J.G., Shelton R., Nikitin N., et al. Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: a report from the SPORTIF III and V trials. Eur J Heart Fail 9 (2007) 730-739
29. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
30. Subramanian U., Weiner M., Gradus-Pizlo I., et al. Patient perception and provider assessment of severity of heart failure as predictors of hospitalization. Heart Lung 34 (2005) 89-98
31. Street Jr. R.L., Krupat E., Bell R.A., Kravitz R.L., and Haidet P. Beliefs about control in the physician-patient relationship: effect on communication in medical encounters. J Gen Intern Med 18 (2003) 609-616
32. Cooper-Patrick L., Gallo J.J., Gonzales J.J., et al. Race, gender, and partnership in the patient-physician relationship. JAMA 282 (1999) 583-589
33. Tabenkin H., Goodwin M.A., Zyzanski S.J., Stange K.C., and Medalie J.H. Gender differences in time spent during direct observation of doctor-patient encounters. J Womens Health (Larchmt) 13 (2004) 341-349
34. Street Jr. R.L., Gordon H.S., Ward M.M., Krupat E., and Kravitz R.L. Patient participation in medical consultations: why some patients are more involved than others. Med Care 43 (2005) 960-969
35. McDonagh T.A., Morrison C.E., Lawrence A., et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 350 (1997) 829-833
36. Cleland J.G., Swedberg K., Follath F., et al. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24 (2003) 442-463
37. Ekman I., Cleland J.G., Swedberg K., et al. Symptoms in patients with heart failure are prognostic predictors: insights from COMET. J Card Fail 11 (2005) 288-292
38. Cleland J.G., Goode K., Erhardt L., et al. A description of the clinical characteristics at baseline of patients recruited into the Carvedilol or Metoprolol European Trial (COMET). Cardiovasc Drugs Ther 18 (2004) 139-152
39. Verbrugge L.M. Sex differences in complaints and diagnoses. J Behav Med 3 (1980) 327-355
40. Bennett J.A., Riegel B., Bittner V., and Nichols J. Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. Heart Lung 31 (2002) 262-270
41. Green C.P., Porter C.B., Bresnahan D.R., and Spertus J.A. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 35 (2000) 1245-1255
42. Rector T.S., Kubo S.H., and Cohn J.N. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol 71 (1993) 1106-1107
43. Kind P., Dolan P., Gudex C., and Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 316 (1998) 736-741
44. Cleland J.G., Swedberg K., Cohen-Solal A., et al. The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York. Eur J Heart Fail 2 (2000) 123-132
45. Cleland J.G., Cohen-Solal A., Aguilar J.C., et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 360 (2002) 1631-1639